Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Clinical trial NCT00247975 · TERMINATED
Trial details
- NCT number
- NCT00247975
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-10-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.